drugset / Trial / NCT00686621
Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)
Summary
The purpose of this study is to provide posaconazole compassionate treatment to patients with invasive fungal infections: 1) which are resistant to standard antifungal therapies; 2) for which there are no effective therapies; 3) with a prior history of serious, severe, or life-threatening toxicities while receiving standard antifungal therapies, or 4) with pre-existing organ dysfunction which precludes the use of standard antifungal therapies.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Posaconazole | Small molecule | 200 mg | Oral |
| Subject | Posaconazole | Small molecule | 400 mg | Oral |